The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MicroRNAs induced in melanoma treated with combination targeted therapy of temsirolimus and bevacizumab.
Aubrey G Wagenseller
No relevant relationships to disclose
Amber L Shada
No relevant relationships to disclose
Kevin D'Auria
No relevant relationships to disclose
Cheryl F. Murphy
No relevant relationships to disclose
Dandan Sun
No relevant relationships to disclose
Kerrington R. Molhoek
No relevant relationships to disclose
Jason A Papin
No relevant relationships to disclose
Anindya Dutta
No relevant relationships to disclose
Craig L. Slingluff
No relevant relationships to disclose